Lumiera Health (TSXV:NHP.H) ROC %: -19.67% (As of Aug. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Lumiera Health ROC %?

Lumiera Health TSXV:NHP.H ROC % is -19.67% as of Aug. 2023.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Lumiera Health's annualized return on capital (ROC %) for the quarter that ended in Aug. 2023 was -19.67%.

As of today (2026-07-17), Lumiera Health's WACC % is 0.00%. Lumiera Health's ROC % is 0.00% (calculated using TTM income statement data). Lumiera Health earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Lumiera Health  (TSXV:NHP.H) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Lumiera Health's WACC % is 0.00%. Lumiera Health's ROC % is 0.00% (calculated using TTM income statement data). Lumiera Health earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Lumiera Health ROC % Related Terms


Lumiera Health ROC % Historical Data

* Premium members only.

The historical data trend for Lumiera Health's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lumiera Health ROC % Chart

Lumiera Health Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Nov18 Nov19 Nov20 Nov21 Nov22
ROC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -68.08 -232.31 -59.42 -84.57 -97.56

Lumiera Health Quarterly Data
Sep18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -60.12 -82.58 -4.35 -19.05 -19.67

Lumiera Health ROC % Calculation

Lumiera Health's annualized Return on Capital (ROC %) for the fiscal year that ended in Nov. 2022 is calculated as:

ROC % (A: Nov. 2022 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Nov. 2021 ) + Invested Capital (A: Nov. 2022 ))/ count )
=-1.398 * ( 1 - 0% )/( (1.333 + 1.533)/ 2 )
=-1.398/1.433
=-97.56 %

where

Lumiera Health's annualized Return on Capital (ROC %) for the quarter that ended in Aug. 2023 is calculated as:

ROC % (Q: Aug. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: May. 2023 ) + Invested Capital (Q: Aug. 2023 ))/ count )
=-0.248 * ( 1 - 0% )/( (1.186 + 1.335)/ 2 )
=-0.248/1.2605
=-19.67 %

where

Note: The Operating Income data used here is four times the quarterly (Aug. 2023) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of -19.67% mean?
Lumiera Health (TSXV:NHP.H) has a ROC % of -19.67% as of Aug. 2023. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Lumiera Health and its competitors.
Is Lumiera Health's ROC % too high?
Lumiera Health's current ROC % is -19.67%.
How does Lumiera Health's ROC % compare to ZTS and CTLT?
Lumiera Health's ROC % of -19.67% can be compared against companies in the Drug Manufacturers industry. The industry median ROC % is 4.46. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Drug Manufacturers company?
The median ROC % among Drug Manufacturers companies is 4.46, based on 990 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Lumiera Health and its competitors. For the Drug Manufacturers industry, the median ROC % is 4.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lumiera Health's current ROC % is -19.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lumiera Health stock overvalued right now?
Lumiera Health (TSXV:NHP.H) has a current ROC % of -19.67%. The current ROC % is -19.67%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Lumiera Health (TSXV:NHP.H), the current ROC % is -19.67% as of Aug. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lumiera Health Business Description

Address 4500 Kimber, Suite 26, Saint-Hubert, QC, CAN, J3Y 8K5
Lumiera Health Inc operates as a product development, marketing and sales business of natural products that outsources the manufacturing of products to third-party manufacturing partners/suppliers. The company sells natural and homeopathic products as well as the development and commercialization of botanical-based products for low-risk agricultural use and human health care.